|Publication type:||Conference other|
|Type of review:||No review|
|Title:||Impact of a diabetes disease management program on guideline-adherent care, hospitalizations and health care costs : a propensity score matching study using real-world data|
|Conference details:||13th European Conference of Health Economics (EuHEA), Oslo, Norway, 5-8 July 2022|
|Subject (DDC):||362.1041: Health economics |
616: Internal medicine and diseases
|Abstract:||Objective: To evaluate the impact of a disease management program (DMP) for patients with diabetes mellitus in a Swiss primary care setting. Methods: In a prospective observational study, we compared diabetes patients in a DMP (intervention group; N=515) with diabetes patients receiving usual care (control group; N=4820) using propensity score matching with entropy balancing. Using a difference-in-difference (DiD) approach we compared changes in outcomes from baseline (2017) to one-year (2017/18), to two-year (2017/19) and to three-year follow-up. Outcomes included four measures for guideline-adherent diabetes care, hospitalization risk, and health care costs. Results: We identified a positive impact of the DMP on the share of patients fulfilling all measures for guideline-adherent care [DiD 2017/18: 7.1%-points, p<0.01; 2017/19: 8.8%-points, p<0.001; 2017/20: 7.3%-points, p<0.01]. The hospitalization risk was lower in the intervention group in all years, but only statistically significant in the one-year follow-up [DiD 2017/18: -5.2%-points, p<0.05; 2017/19: -3.4%-points, not sign.; 2017/20: -4.2%-points, not sign.]. The increase in health care costs was smaller in the intervention than in the control group [DiD 2017/18: CHF -738; 2017/19: CHF -1051, 2017/20: CHF -612], but this effect was not statistically significant. Discussion: The DMP under evaluation seems to exert a positive impact on the quality of diabetes care, reflected in the increase in the measures for guideline-adherent care and in a reduction of the hospitalization risk in the intervention group. It also might reduce health care costs, but only a longer follow-up will show whether the observed effect persists over time.|
|Fulltext version:||Published version|
|License (according to publishing contract):||Licence according to publishing contract|
|Departement:||School of Management and Law|
|Organisational Unit:||Winterthur Institute of Health Economics (WIG)|
|Appears in collections:||Publikationen School of Management and Law|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.